In post-menopausal women, there was a significant inverse association between SHBG and breast cancer risk (HR per 30 nmol/L increment: 0.89; 95% CI: 0.84, 0.94) (Table 2 and Supplementary Fig. S2). The gene discussed is SHBG; the disease is breast cancer.